Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Oxaliplatin is a key chemotherapy drug for gastric cancer, but its efficacy is limited by side effects and drug resistance.
• Natural products are being explored to enhance chemotherapy effectiveness and reduce toxicity.
• Genipin, from Gardenia jasminoides, exhibits various bioactivities, but its role in gastric cancer therapy with oxaliplatin was unknown.

Purpose of the Study:

• To investigate if genipin can sensitize gastric cancer cells to oxaliplatin.
• To elucidate the underlying mechanisms of genipin's effect on oxaliplatin-induced cell death.

Main Methods:

• Colony forming assay, FACS analysis, and western blotting were used to assess cell viability and apoptosis.
• Gene expression analysis (p53, LC3) and knockdown studies were performed.
• Cell lines used: AGS, MKN45, and MKN28.

Main Results:

• Genipin significantly sensitized gastric cancer cells to oxaliplatin-induced apoptosis.
• Genipin upregulated p53 expression and induced autophagy, evidenced by increased LC3 expression.
• Knockdown of LC3 reduced the enhanced cell death observed with the combination therapy.

Conclusions:

• Genipin acts as a sensitizer for oxaliplatin in gastric cancer treatment.
• The mechanism involves p53-dependent induction of autophagy via the DRAM pathway.
• Genipin holds potential for improving oxaliplatin-based gastric cancer therapy.